In this phase II , single-blind , randomized , controlled study , adults aged 60years ( N = 714 ) received one dose of 100ggE/AS01B , two doses , two months apart , of 25 , 50 , or 100ggE/AS01B , or two doses of unadjuvanted 100ggE/saline .